PCSC · Perceptive Capital Solutions Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $858.8K | - | $856.2K | $193.2K | $256.0K | - | $196.1K | $122.0K |
| D&A | - | - | - | - | - | - | - | - |
| Operating Income | ($858.8K) | - | ($856.2K) | ($193.2K) | ($256.0K) | - | ($196.1K) | ($122.0K) |
| Interest Expense | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - |
| Net Income | ($51.7K) | - | $144.6K | $754.8K | $678.6K | - | $981.5K | $87.5K |
| EPS - Basic | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $567.2K | $865.0K | $1.18M | $1.34M | $0 | $1.13M | $1.21M | $0 |
| Accounts Receivable | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - |
| Current Assets | $649.7K | $907.6K | $1.26M | $1.47M | $1.34M | $1.24M | $1.37M | $1.43M |
| Total Assets | $93.33M | $92.78M | $92.20M | $91.40M | $90.63M | $89.90M | $89.01M | $87.89M |
| Current Liabilities | $2.86M | $2.25M | $934.6K | $281.2K | $265.6K | $210.8K | $160.0K | $28.4K |
| Long-term Debt | - | - | - | - | - | - | - | - |
| Total Liabilities | $6.31M | $5.70M | $4.38M | $3.73M | $3.72M | $3.66M | $3.61M | $3.48M |
| Stockholders' Equity | ($5.66M) | ($4.80M) | ($3.12M) | ($2.27M) | ($2.37M) | ($2.12M) | ($1.94M) | ($1.74M) |
| Retained Earnings | ($5.66M) | ($4.80M) | ($3.12M) | ($2.27M) | ($2.37M) | ($2.12M) | ($1.94M) | ($1.74M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($297.9K) | - | - | - | ($237.7K) | - | - | ($196.3K) |
| Investing Cash Flow | $0 | - | - | - | $300.0K | - | - | ($86.25M) |
| Financing Cash Flow | - | - | - | - | - | - | - | $87.73M |
| CapEx | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 |
|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||
| Gross margin | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - |
| Return on assets | -0.1% | - | 0.2% | 0.8% | 0.7% | - | 1.1% | 0.1% |
| Return on equity | 0.9% | - | -4.6% | -33.3% | -28.6% | - | -50.6% | -5.0% |
| Return on invested capital | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||
| Current ratio | 0.23 | 0.40 | 1.35 | 5.21 | 5.06 | 5.90 | 8.56 | 50.57 |
| Quick ratio | 0.23 | 0.40 | 1.35 | 5.21 | 5.06 | 5.90 | 8.56 | 50.57 |
| Cash ratio | 0.20 | 0.38 | 1.26 | 4.78 | 0.00 | 5.36 | 7.56 | 0.00 |
| Leverage | ||||||||
| Debt / Equity | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - |
| Equity multiplier | -16.50 | -19.34 | -29.54 | -40.35 | -38.21 | -42.48 | -45.88 | -50.40 |
| Liabilities / Assets | 0.07 | 0.06 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Efficiency | ||||||||
| Asset turnover | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - |
| Valuation | ||||||||
| P / E | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| Growth | ||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -235.5% | - | -336.5% | -58.4% | - | - | - | - |
| Net income growth (YoY) | - | - | -85.3% | 762.9% | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -138.4% | -126.7% | -60.9% | -29.9% | - | - | - | - |
Peer comparison
Same SIC group: Services-Medical Laboratories
Comparing Perceptive Capital Solutions Corp against the 5 most active filers in the same SIC group.